Advertisement

Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells

      Abstract

      Objectives

      Smooth muscle cell (SMC) proliferation is a major feature in atherosclerosis, since it contributes to the formation of the fibrous cap, thus to plaque stability, but also to arterial stenosis and post-angioplasty restenosis. Among the various mitogenic signaling pathways involved in SMC proliferation, the mTOR pathway regulates both the cell cycle and cell growth. Resveratrol, a polyphenolic compound from grapes and red wine, has potential anti-atherogenic and anti-cancer properties. This work was designed to investigate the activation of the mTOR pathway by the proatherogenic oxidized LDL (oxLDL) in SMC, and the potential inhibitory effect of resveratrol.

      Results

      mTOR and its downstream target p70S6 kinase are phosphorylated and activated by mitogenic concentrations of oxLDL (50 μg/ml), and are involved in SMC proliferation, as assessed by the inhibitory effect of the mTOR inhibitor rapamycin. The activation of mTOR signaling by oxLDL, requires the upstream activation of PI3K and Akt, as assessed by the inhibitory effect of the PI3K inhibitor Ly294002 on mTOR activation and DNA synthesis. Resveratrol blocked the oxLDL-induced phosphorylation and activation of the PI3K/Akt/mTOR/p70S6K pathway and strongly inhibited both the DNA synthesis and proliferation of SMC. This activity is independent of the anti-oxidant effect and of AMPK activation by resveratrol.

      Conclusion

      These data indicate that the mTOR pathway is activated by oxLDL via PI3K/PDK1/Akt, and is required for SMC proliferation. Resveratrol blocks specifically this pathway, thereby inhibiting oxLDL-induced SMC proliferation. These data highlight a new property for resveratrol that could contribute to the general anti-atherogenic properties of this polyphenol.

      Abbreviations:

      LDL (low density lipoproteins), SMC (smooth muscle cells), oxLDL (oxidized low density lipoprotein), FCS (fetal calf serum), PI3K (phosphoinositide 3 kinase), mTOR (mammalian target of rapamycin)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lusis A.J.
        Atherosclerosis.
        Nature. 2000; 407: 233-241
        • Berliner J.A.
        • Heinecke J.W.
        The role of oxidized lipoproteins in atherogenesis.
        Free Radic Biol Med. 1996; 20: 707-727
        • Auge N.
        • Escargueil-Blanc I.
        • Lajoie-Mazenc I.
        • et al.
        Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low density lipoprotein.
        J Biol Chem. 1998; 273: 12893-12900
        • Auge N.
        • Negre-Salvayre A.
        • Salvayre R.
        • Levade T.
        Sphingomyelin metabolites in vascular cell signaling and atherogenesis.
        Prog Lipid Res. 2000; 39: 207-229
        • Auge N.
        • Garcia V.
        • Maupas-Schwalm F.
        • Levade T.
        • Salvayre R.
        • Negre-Salvayre A.
        Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways.
        Arterioscler Thromb Vasc Biol. 2002; 22: 1990-1995
        • Nave B.T.
        • Ouwens M.
        • Withers D.J.
        • Alessi D.R.
        • Shepherd P.R.
        Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation.
        Biochem J. 1999; 344: 427-431
        • Shaw R.J.
        • Cantley LC
        Ras, PI(3)K and mTOR signalling controls tumour cell growth.
        Nature. 2006; 441: 424-430
        • Sekulic A.
        • Hudson C.C.
        • Homme J.L.
        • et al.
        A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.
        Cancer Res. 2000; 60: 3504-3513
        • Wullschleger S.
        • Loewith R.
        • Hall M.N.
        TOR signaling in growth and metabolism.
        Cell. 2006; 124: 471-484
        • Pace-Asciak C.R.
        • Hahn S.
        • Diamandis E.P.
        • Soleas G.
        • Goldberg D.M.
        The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease.
        Clin Chim Acta. 1995; 235: 207-219
        • Brito P.
        • Almeida L.M.
        • Dinis T.C.
        The interaction of resveratrol with ferrylmyoglobin and peroxynitrite; protection against LDL oxidation.
        Free Radic Res. 2002; 36: 621-631
        • Brito P.M.
        • Mariano A.
        • Almeida L.M.
        • Dinis T.C.
        Resveratrol affords protection against peroxynitrite-mediated endothelial cell death: a role for intracellular glutathione.
        Chem Biol Interact. 2006; 164: 157-166
        • Ou H.C.
        • Chou F.P.
        • Sheen H.M.
        • Lin T.M.
        • Yang C.H.
        • Huey-Herng Sheu W.
        Resveratrol, a polyphenolic compound in red wine, protects against oxidized LDL-induced cytotoxicity in endothelial cells.
        Clin Chim Acta. 2006; 364: 196-204
        • Ungvari Z.
        • Orosz Z.
        • Rivera A.
        • et al.
        Resveratrol increases vascular oxidative stress resistance.
        Am J Physiol Heart Circ Physiol. 2007; 292: H2417-2424
        • Tyagi A.
        • Agarwal R.
        • Agarwal C.
        Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
        Oncogene. 2003; 22: 1302-1316
        • Godichaud S.
        • Si-Tayeb K.
        • Auge N.
        • et al.
        The grape-derived polyphenol resveratrol differentially affects epidermal and platelet-derived growth factor signaling in human liver myofibroblasts.
        Int J Biochem Cell Biol. 2006; 38: 629-637
        • Haider U.G.
        • Sorescu D.
        • Griendling K.K.
        • Vollmar A.M.
        • Dirsch V.M.
        Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells.
        Mol Pharmacol. 2002; 62: 772-777
        • Liu Y.
        • Liu G.
        Isorhapontigenin and resveratrol suppress oxLDL-induced proliferation and activation of ERK1/2 mitogen-activated protein kinases of bovine aortic smooth muscle cells.
        Biochem Pharmacol. 2004; 67: 777-785
        • Tellier E.
        • Negre-Salvayre A.
        • Bocquet B.
        • et al.
        Role for furin in tumor necrosis factor alpha-induced activation of the matrix metalloproteinase/sphingolipid mitogenic pathway.
        Mol Cell Biol. 2007; 27: 2997-3007
        • Auge N.
        • Pieraggi M.T.
        • Thiers J.C.
        • Negre-Salvayre A.
        • Salvayre R.
        Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells.
        Biochem J. 1995; 309: 1015-1020
        • Vacaresse N.
        • Vieira O.
        • Robbesyn F.
        • Jurgens G.
        • Salvayre R.
        • Negre-Salvayre A.
        Phenolic antioxidants trolox and caffeic acid modulate the oxidized LDL-induced EGF-receptor activation.
        Br J Pharmacol. 2001; 132: 1777-1788
        • Burgering B.M.
        • Freed E.
        • van der Voorn L.
        • McCormick F.
        • Bos J.L.
        Platelet-derived growth factor-induced p21ras-mediated signaling is independent of platelet-derived growth factor receptor interaction with GTPase-activating protein or phosphatidylinositol-3-kinase.
        Cell Growth Differ. 1994; 5: 341-347
        • Olson E.R.
        • Naugle J.E.
        • Zhang X.
        • Bomser J.A.
        • Meszaro J.G.
        Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol.
        Am J Physiol Heart Circ Physiol. 2005; 288: H1131-1138
        • Oak M.H.
        • El Bedoui J.
        • Schini-Kerth V.B.
        Antiangiogenic properties of natural polyphenols from red wine and green tea.
        J Nutr Biochem. 2005; 16: 1-8
        • Holme A.L.
        • Pervaiz S.
        Resveratrol in cell fate decisions.
        J Bioenerg Biomembr. 2007; 39: 59-63
        • Zang M.
        • Xu S.
        • Maitland-Toolan K.A.
        • et al.
        Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice.
        Diabetes. 2006; 55: 2180-2191
        • Gwinn D.M.
        • Shackelford D.B.
        • Egan D.F.
        • et al.
        AMPK phosphorylation of raptor mediates a metabolic checkpoint.
        Mol Cell. 2008; 30: 214-226
        • Auge N.
        • Maupas-Schwalm F.
        • Elbaz M.
        • et al.
        Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.
        Circulation. 2004; 110: 571-578
        • Frojdo S.
        • Cozzone D.
        • Vidal H.
        • Pirola L.
        Resveratrol is a class IA phosphoinositide 3-kinase inhibitor.
        Biochem J. 2007; 406: 511-518
        • Haider U.G.
        • Roos T.U.
        • Kontaridis M.I.
        • et al.
        Resveratrol inhibits angiotensin II- and epidermal growth factor-mediated Akt activation: role of Gab1 and Shp2.
        Mol Pharmacol. 2005; 68: 41-48
        • Chan A.Y.
        • Dolinsky V.W.
        • Soltys C.L.
        • et al.
        Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt.
        J Biol Chem. 2008; 283: 24194-24201
        • Pozo-Guisado E.
        • Lorenzo-Benayas M.J.
        • Fernandez-Salguero P.M.
        Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation.
        Int J Cancer. 2004; 109: 167-173
        • Cullen J.P.
        • Morrow D.
        • Ji Y.
        • et al.
        Resveratrol inhibits expression and binding activity of the monocyte chemotactic protein-1 receptor, CCR2, on THP-1 monocytes.
        Atherosclerosis. 2007; 195: e125-133
        • Hill M.M.
        • Hemmings B.A.
        Inhibition of protein kinase B/Akt implications for cancer therapy.
        Pharmacol Ther. 2002; 93: 243-251
        • Chao H.H.
        • Juan S.H.
        • Liu J.C.
        • et al.
        Resveratrol inhibits angiotensin II-induced endothelin-1 gene expression and subsequent proliferation in rat aortic smooth muscle cells.
        Eur J Pharmacol. 2005; 515: 1-9
        • Jung S.N.
        • Yang W.K.
        • Kim J.
        • et al.
        Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells.
        Carcinogenesis. 2008; 29: 713-721

      Linked Article